Table 9.
Factors associated with the affordability of anticancer medicines.
| Factors | B | Wald | OR (95%CI) | p |
|---|---|---|---|---|
| Survey year (reference = 2012) | ||||
| 2016 | 0.53 | 14.72 | 1.69 (1.29–2.22) | <0.001 |
| Medicine variety (reference = OBs) | ||||
| LPGs | 2.75 | 281.67 | 15.60 (11.32–21.51) | <0.001 |
| Area (reference = rural area) | ||||
| Urban area | 0.64 | 21.34 | 1.89 (1.44–2.48) | <0.001 |
| Income level (reference = low income) | ||||
| Middle income | 0.12 | 0.55 | 1.13 (0.82–1.56) | 0.457 |
| High income | 0.46 | 7.51 | 1.59 (1.14–2.20) | 0.006 |
| Covered by BMI or not (reference = not covered) | ||||
| Covered by BMI | 1.59 | 79.39 | 4.92 (3.46–6.98) | <0.001 |
| WHO essential medicine (reference = non-WHO essential medicine) | ||||
| WHO essential medicine | 1.01 | 40.84 | 2.75 (2.02–3.75) | <0.001 |
Note: Outcome (y)—affordable or not; y = 0, not affordable; y = 1, affordable; BMI, basic medical insurance in the Jiangsu Province.